The crisis in Ukraine has impacted the CDM world in fundamental ways in a very short period of time. Biopharma companies need to be prepared to tackle an uncertain and volatile political and economic climate, whilst navigating Clinical Trial issues as well as supporting employees, teams and patients in the affected regions.
SCDM invites you to understand the implications the Russia-Ukraine crisis will have on clinical trials, such as protocol deviations, missing and/or delayed data, missing visits assessments, and team and patient welfare.
Join us for a top-level panel discussion and Q&A exploring these challenges.
Don’t miss it! Add event to calendar